increased mortality and enhanced hepatocyte deaths. During the early stages of liver repair after CCl 4 T he liver is the major organ to manage the detoxification of both exogenous and endogenous insults and therefore is constantly exposed to injury agents. Liver repair is an intrinsic defense mechanism to protect liver from injury. Impaired liver repair will lead to fibrogenesis and cirrhosis, which may eventually result in either liver failure or hepatocellular carcinoma. Many genes and pathways have been identified to regulate liver repair.
Farnesoid X receptor (FXR) belongs to the nuclear hormone receptor superfamily and is highly expressed in liver, intestine, kidney, and adrenal glands (1) . FXR is the primary bile acid (BA) receptor that acts as a master regulator of BA homeostasis (2) (3) (4) (5) (6) (7) . BAs are end products of cholesterol catabolism and are essential for normal absorption of cholesterol, lipids, and fat-soluble vitamins by the intestine (8) . BAs are synthesized in the liver and stored in the gall bladder. They are secreted into the intestine after food intake, but most BAs (95%) are reabsorbed and transported back to the liver through the portal vein. This system is known as enterohepatic circulation. The levels of BAs need to be tightly controlled due to their surfactant properties and hepatotoxicity at high doses. Accumulation of BAs in the liver, which may occur during intrahepatic cholestasis of pregnancy (9) , or inherent diseases such as progressive familial intrahepatic cholestasis 1 and 2 (PFIC1 and PFIC2) (10 -12) , results in hepatocellular apoptosis and necrosis, thereby promoting liver fibrosis and cirrhosis (13) .
To prevent the BA hepatotoxicity, liver has an intrinsic mechanism with which to sense and control BA levels by FXR. In PFIC1 patients, the decreased FXR activity is regarded as one of the primary reasons of the pathogenesis (10) . Functional variants of FXR are detected in patients with intrahepatic cholestasis of pregnancy (9) . Function of FXR in cholestasis is further clarified by the synthetic FXR agonist, GW4064, which prevents cholestatic liver diseases induced by bile duct ligation (BDL) through down-regulating BA synthetic genes and increasing expression of BA transport genes (14) . Another FXR agonist, 6-ethyl-chenodeoxycholic acid, effectively suppresses the liver fibrosis caused by BDL in rats (13) . Knockout of small heterodimer partner (SHP), the primary target gene of FXR, leads to increased liver damage by BDL (15) , which also supports the roles of FXR in liver protection. In a recent study, FXR Ϫ/Ϫ mice were shown to be more susceptible to ␣-naphthyl isothiocyanate-induced acute intrahepatic cholestatic liver injury (16) . However, the role of FXR in liver repair after injury is still not very clear. We previously showed that FXR was required for normal liver regeneration after injury in a 70% partial hepatectomy (PH) model by promoting proliferation of liver cells (17) . Rodents treated with CCl 4 are widely used to study the mechanisms of toxin-induced liver injury (18, 19) . CCl 4 -induced hepatic injury is characterized by centrilobular necrosis and followed by hepatic fibrosis, which recapitulates drug-induced acute liver failure. Compared with 70% PH model, which leaves the remaining 30% of the liver intact, CCl 4 injection model of liver injury and repair is closer to the clinical liver injury cases with simultaneous severe hepatocyte deaths and acute cholestasis. Therefore, we use this model to ask: 1) whether FXR is also required for normal liver repair in response to CCl 4 -induced hepatic cell deaths as it does in the 70% PH surgical model; 2) whether CCl 4 -induced hepatic necrosis and apoptosis potentially disrupt BA homeostasis, and whether this disruption will interfere with the normal liver repair process. BAs are synthesized specifically from cholesterol in the liver and subsequently excreted into bile. We observed a significant increase of serum BA levels after CCl 4 injection in the wild-type mice, which suggests that liver injury caused by CCl 4 may impair enterohepatic circulation and BA homeostasis (Fig. 2A) (Fig. 3A) . In contrast, the intrahepatic BA level was sharply increased in the FXR Ϫ/Ϫ mice during the acute phase and kept at a much higher level than that in wild-type controls until 7 d after the treatment. The expression of the major BA synthetic enzyme CYP7A1 was significantly increased in the FXR Ϫ/Ϫ mice at the second hour whereas the CYP7A1 in the wild-type mice was not greatly increased compared with the nontreated control ( Fig. 3B) . BSEP is responsible for the transport of taurocholate and other cholate conjugates from hepatocytes to the bile, and its expression is activated by FXR (20) . The early activation of BSEP transcription was not seen in the FXR Ϫ/Ϫ mice, and the expression levels were less than 50% of those in the wild-type controls at most of the time points (Fig. 3C ). FXR reduces the BAs inside the hepatocytes also by suppressing NTCP expression. This suppression was slightly impaired in the FXR Ϫ/Ϫ mice in the acute phase after liver injury (Fig. 3D ). The expression of OATP1, the organic anion-transporting peptide that helps hepatocytes uptake BAs together with NTCP at the basolateral membrane of hepatocytes, was decreased by CCl 4 treatment in wild-type mice. The FXR Ϫ/Ϫ mice showed much lower levels of OATP1 expression in liver both before CCl 4 treatment and during liver repair ( 
Results

Defective
Exogenous overexpression of a constitutively active FXR suppressed liver injury after CCl 4 treatment
Of interest, the expression of FXR was strongly suppressed after CCl 4 treatment (Fig. 4A ), raising the question of whether it is the decreased FXR expression that contributes to liver injury. Therefore we infected the wildtype mice with an adenovirus expressing a constitutively active form of FXR, FXR-VP16, as described previously to test whether FXR overexpression rescues CCl 4 -induced liver injury (Supplemental Fig. 2A ) (22) . Compared with the controls infected with adenovirus expressing VP16 only, the mice infected with FXR-VP16 showed increased expression of SHP and reduced expression of (Fig. 4B) . Two genes regulating the cell cycle, FoxM1B and Cyclin D1, were increased by FXR-VP16 infection (Fig. 4B) . Overexpression of FXR-VP16 effectively reduced serum BA levels and ALT levels and rescued apoptosis and necrosis of the hepatocyte after CCl 4 administration (Fig. 4, C and D) . The proliferation of the hepatocytes, as shown by BrdU staining, was simultaneously increased (Fig. 4, C 
and E).
Reduced signal transducer and activator of transcription 3 (STAT3) activities in FXR
؊/؊ mice during early time points after CCl 4 treatment Hepatocytes normally exist in a highly differentiated quiescent G 0 phase. Upon injury, the remaining hepatocytes are primed by protooncogenes such as c-fos, c-jun, and c-myc, the cytokines, TNF␣ and IL-6, and acute phase response factors including nuclear factor-B (NF-B) and STAT3 (23) .
The induction of c-jun and c-fos is similar between the FXR Ϫ/Ϫ mice and the wild-type mice (Fig. 5A) . However, the FXR Ϫ/Ϫ mice exhibited surprisingly high levels of cmyc induction (Fig. 5A) . Although certain level of c-myc expression can promote the initiation of hepatocyte proliferation, the overactivation of c-myc may lead to cellular senescence and apoptosis in the liver (24).
CCl 4 preferentially induces TNF␣ production in its early phase (25) . In the wild-type mice, TNF␣ was induced and achieved a peak at the second hour, and its expression level was still maintained at the eighth hour. FXR Ϫ/Ϫ mice had preexisting high levels of TNF␣ and the expression was further enhanced by CCl 4 and almost 2-fold higher than that in wild-type livers (Fig. 5B) . The exaggerated TNF␣ might result in overexpression of c-myc and contribute to the increased necrosis and apoptosis in FXR Ϫ/Ϫ livers. IL-6 is a cytokine that plays a mainly protective role during liver injury. The induction of this cytokine was seen as early as the second hour, and the magnitude of induction could achieve a higher level on the eighth hour. However, no significant difference of IL-6 production in the acute phase was seen between the wild-type and the FXR Ϫ/Ϫ mice (Fig. 5B ).
However, we observed a dramatically reduced DNA-binding activity of STAT3 in the FXR Ϫ/Ϫ livers (Fig. 6A ). Whereas STAT3 activity was strongly up-regulated in the wild-type livers 2 h after CCl 4 injection, this induction was much less in the FXR Ϫ/Ϫ livers. The result was further confirmed by Western blotting, which showed less STAT3 tyrosine phosphorylation in the FXR Ϫ/Ϫ livers (Fig. 6B ). In addition, the STAT3 phosphorylation at later time points, which correlates with the initiation of the second round of the hepatocyte proliferation, was delayed in the FXR Ϫ/Ϫ livers until 2 d after the treatment, but FXR Ϫ/Ϫ mice showed greatly enhanced hepatic STAT3 phosphorylation at 3 d after the treatment. We also investigated NF-B activation by measuring the nuclear translocation of p65, a catalytic subunit of NF-B. There was a comparable increase in the levels of p65 in the nucleus of the wild-type and the FXR Ϫ/Ϫ livers after CCl 4 injection (Fig. 6C) . To further confirm the defective STAT3 activation in the FXR Ϫ/Ϫ livers, we measured the expression of two STAT3 target genes Bcl-xl and SOCS3 (26, 27) in the acute responses after CCl 4 treatment. Consistent with the STAT3 DNA-binding activity pattern, induction of Bcl-xl and SOCS3 was either decreased or delayed in the FXR Ϫ/Ϫ livers compared with induction of these two genes in the wild-type livers (Fig. 6D) rus expressing FXR-VP16 itself lowered basal levels of serum ALT and BAs of FXR Ϫ/Ϫ mice compared with control adenovirus that expressed VP16 alone (Supplemental Fig. 2B ). The FXR-VP16 adenovirus restored the phosphorylation of STAT3 in the acute phases after CCl 4 treatment (Fig. 6E) as well as promoted the expression of the STAT3 target gene SOCS3 (Fig. 6F ) without changing hepatic IL-6 expression (Supplemental Fig. 3A) . These results suggest a role of FXR for normal STAT3 activation in the acute phase of liver injury.
High levels of BAs suppress STAT3 phosphorylation during liver regeneration
We then tested whether FXR activation directly affected the STAT3 phosphorylation in primary hepatocytes. FXR ligand GW4064 was not able to initiate STAT3 phosphorylation or prolong IL-6-induced STAT3 phosphorylation of the wild-type primary hepatocytes although the effectiveness of GW4064 on FXR activation was shown by the increased ERK1/2 phosphorylation (28) (Fig. 7A) . Furthermore, no significant difference of IL-6-induced STAT3 phosphorylation was observed between the wild-type and the FXR Ϫ/Ϫ primary hepatocytes (Fig. 7B) . A major deregulation in the FXR Ϫ/Ϫ mice was the sustained higher levels of BAs in serum and liver. Therefore, we tested whether high BA levels would affect STAT phosphorylation. We first fed the mice with a 4% cholestyramine (Resin) diet to reduce BA levels in FXR Ϫ/Ϫ mice as we previously described (17) . Indeed, we observed a reduced suppression of STAT3 phosphorylation after CCl 4 treatment by Resin feeding compared with the controls (Fig. 7C) . On the other hand, when we fed the wild-type mice with a 1% cholic acid (CA) diet, we observed a suppression of STAT3 phosphorylation after CCl 4 treatment (Fig. 7C and Supplemental Fig. 4A ). This suppression of hepatic STAT3 phosphorylation by 1% CA feeding was even more prominent in the wild-type mice with 70% PH (Fig. 7C and Supplemental Fig. 4B ). These results suggest that high levels of BAs contribute to the reduced STAT3 phosphorylation in the FXR Ϫ/Ϫ livers after CCl 4 treatment. However, neither Resin-nor CA-containing diet altered hepatic IL-6 expression (Supplemental Fig. 3 , B-D).
BAs are known to directly modulate phosphorylation of STAT3 by affecting its upstream components (29, 30) . It was reported that certain hydrophobic BAs such as glycochenodeoxycholic acid (GCDCA) down-regulated IL-6-induced STAT3 phosphorylation through both gp130-dependent and p38␣-dependent pathways. Treatment of GCDCA to cultured rat primary hepatocytes caused caspase-mediated gp130 degradation (30) . Therefore, we compared gp130 protein levels between the 1% CA-containing diet feeding mice and the mice fed with the normal diet after 70% PH, and between the FXR Ϫ/Ϫ mice and the wild-type mice treated with CCl 4 . However, no significant difference was observed (Supplemental Figs. 4C and 7D ). The levels of p38␣ phosphorylation between the two groups were comparable (Fig. 7D) . Furthermore, there was no difference in the induction of p38␣ phosphorylation between 1% CA-containing diet-fed mice and the wild-type controls (Supplemental Fig. 4C ). STAT3 pathways are known to be directly regulated mainly through another two upstream components, Janus kinase (JAK)1 and JAK2, the phosphorylated forms of which, in turn, phosphorylate STAT3 (23, 31) . We found that phosphorylation of both JAK1 and JAK2 was impaired in the FXR Ϫ/Ϫ mice. Thus we speculated whether BAs affected phosphorylation of JAK1 and JAK2 through a gp130-and p38␣-independent pathway. Indeed, 4% Resincontaining diet effectively restored phosphorylation of JAK1 and JAK2 in the FXR Ϫ/Ϫ mice after CCl 4 treatment (Fig. 7E ). In addition, 1% CA-containing diet greatly reduced phosphorylation of both JAK1 and JAK2 in the wildtype mice after 70% PH (Fig. 7F) . Furthermore, we observed that the CA-containing diet would augment CCl 4 -induced Hydrodynamic injection resulted in STAT3 protein expression in liver and enhanced expression of STAT3 target gene Bcl-xl (Fig. 8A) . We then treated the mice with CCl 4 (750 l/kg) 1 d after the hydrodynamic transfection. Exogenous overexpression of STAT3C significantly reduced ALT levels, hepatocyte deaths, and liver injury after CCl 4 treatment in FXR Ϫ/Ϫ mice, whereas FXR Ϫ/Ϫ mice with the treatment of a control plasmid did not show different responses to CCl 4 compared with the mice receiving saline only (Fig. 8, B-F) . These results demonstrate that diminished STAT3 activity in the FXR Ϫ/Ϫ livers after CCl 4 treatment may contribute to the enhanced hepatocyte deaths. 
Discussion
Liver repair is an intrinsic defense mechanism after injury. The impact of the liver metabolic pathways on liver injury and repair has not been well studied. We observe that CCl 4 -induced liver injury disrupts the BA enterohepatic circulation and causes the accumulation of BAs in the liver. This may result from the repression of FXR expression and other key components involved in BA circulation such as the BA transporters. The suppression of FXR expression may be due to the increase of proinflammatory cytokines induced by strong liver injury (33) . Interestingly, we observed a transient increase of FXR mRNA levels shortly after CCl 4 treatment. This could be due to the fact that FXR activation by increased BA flow up-regulates the transcription of FXR. BAs as well as FXR ligands, CDCA and GW4064, are shown to increase FXR mRNA levels (34, 35) . The key role of FXR in controlling BA levels after CCl 4 treatment was confirmed by FXR Ϫ/Ϫ mice that displayed severe cholestasis and exaggerated liver injury. Previous studies indicate that high levels of BAs can induce cell death and augment inflammatory cytokine production such as TNF␣ (Fig. 5B) (36) . TNF␣ biosynthesis is required for liver repair after CCl 4 treatment, but overproduction of TNF␣ can induce more apoptosis mediated by TNF receptor/Fas-associates death domain pathways (37) . Therefore, the uncontrolled inflammatory cytokine production due to high levels of BAs may contribute to the overall liver injury.
In this study, we also identify a specific effect of BAs on STAT3 activation. STAT3 signaling pathway, usually activated in the acute phase of liver injury, is a previously identified important pathway for survival and repair of liver cells. Here we show that overload of BAs caused by FXR deficiency leads to delayed responses of STAT3 to liver injury. Tyrosine phosphorylation of STAT3 was severely repressed in the FXR Ϫ/Ϫ livers in the acute phase of CCl 4 -induced liver injury, although stronger responses of STAT3 were observed in the later stages of liver repair in FXR Ϫ/Ϫ mice.
The compensatory hyperphosphorylation of STAT3 in the FXR Ϫ/Ϫ livers at the later stages was probably due to either the release of BA stress, such as compensatory exportation and conjugation of toxic hydrophobic BAs, or more aggravated inflammation caused by massive cell deaths in these mice, which may help to explain the accelerated recovery of FXR Ϫ/Ϫ mice after 3 d in the second round of hepatocyte cell cycling after injury (38).
We did not observe a direct effect of FXR on either basal or IL-6-induced STAT3 phosphorylation. Instead, we provide evidence that high levels of BAs in FXR in CCl 4 treatment. Indeed, an exogenous supplement of BAs suppresses STAT3 phosphorylation in 70% PH livers. It is well known that cholestatic livers have impaired liver regeneration and display higher grades of liver injury (39) . A previous study reported that BA treatment on rat hepatocytes in vitro can inhibit IL-6-induced STAT3 phosphorylation via a gp130-and p38␣-dependent manner (30) . However, we did not observe the similar mechanisms in our FXR Ϫ/Ϫ mouse models or 1% CA-containing diet models of cholestasis. This is potentially because the dose of the hydrophobic BA (GCDCA) that the two groups used in vitro, 100 M, was not easily achieved in our cholestasis models. In contrast, we observed that high levels of BAs would directly modulate phosphorylation of JAK1 and JAK2, two direct upstream components of STAT3 and well-accepted main transducers of STAT3 pathways in liver regeneration (40) . Our results thus indicate that the interference with STAT3 activation by high levels of BAs in damaged liver contributes to the defective liver repair. It should be mentioned that loss of other IL-6 family cytokines, such as IL-11, oncostatin M, leukemia inhibitory factor, and complement C3 may also be involved in the deficient STAT3 activation in the FXR Ϫ/Ϫ mice after CCl 4 treatment because of their documented roles in liver regeneration (41, 42) . Our previous studies suggest a novel role of FXR in promoting liver regeneration after 70% PH (17) . However, there are intrinsic differences of responses between 70% PH and CCl 4 -induced liver injury. In 70% PH, no significant apoptosis or necrosis is seen (17) . In contrast, in CCl 4 -induced injury, there is strong cell death and liver necrosis. The response of hepatocytes to cytokine pathways, such as STAT3 phosphorylation, in these two different types of liver damage is different also. Although the transient increase of BA will promote liver regeneration by activating FXR, it may aggravate liver injury after CCl 4 treatment. Therefore, we consider BA as a stress signal, and its function in liver repair depends on the status of FXR and the type of liver injury (43) .
In summary, we demonstrate that FXR is essential to promote liver repair after injury. On one hand, FXR activation can directly transform the stress of BA overload into force of promotion of liver repair. For example, FXR promotes liver regeneration by regulating expression of genes involved in cell cycle progression such as FoxM1b. We also have evidence that FoxM1b is a FXR direct target gene (44) . Therefore, FXR may direct a program of gene expression to promote liver regeneration after injury. On the other hand, FXR activation will help release the BA overload in liver, which can prevent BA-induced cell deaths and other deleterious effects on normal liver repair pathways such as STAT3 signaling. We propose that FXR is a novel liver protector (21) . Therefore, FXR may represent a novel target of drug development to promote liver repair and to treat liver-injury related diseases. 
Materials and Methods
Animal maintenance and treatments
Wild-type and FXR Ϫ/Ϫ mice were maintained as previously described (17) . After an overnight fast, 8-to 12-wk-old mice were injected ip with a single dose of CCl 4 (750 l/kg in corn oil) or vehicle control as the zero time point. All procedures followed the National Institute of Health guidelines for the care and use of laboratory animals. The cholestyramine or the cholic acid feedings are described previously (17) .
RNA preparation and quantitative real-time PCR
RNA preparation was described previously (22) . mRNA was quantified by real-time quantitative PCR using an Applied Biosystems 7300 Fast Real-Time PCR System (Applied Biosystems, Foster City, CA). The sequences of primers for each gene are provided in Supplemental Table 1 .
EMSAs
Liver nuclear extract was prepared as described previously (22) . Nuclear extracts (6 g), polydeoxyinosinic deoxycytidylic acid (3 g), and 32 P-radiolabeled oligonucleotides were coincubated for 30 min and separated by electrophoresis. For signal transducer and activator of transcription (STAT) 3-DNA binding analysis, double-stranded radiolabeled oligonucleotide high-affinity serum inducible element (5Ј-ATCCTCCAG-CATTTCCCGTAAATCCTC-3Ј) was added to the mixture. The mixture was subjected to 5% nondenaturing gel electrophoresis. The gel was dried on chromatography paper (Whatman, Florham Park, NJ) and exposed overnight at Ϫ80 C using BioMax MS film (Eastman Kodak, Rochester, NY).
Western blotting
Liver total protein was prepared and separated as described previously (22) . After blocking in 5% nonfat milk, the membranes were exposed to specific primary antibodies [anti-STAT3, antip65, antiphospho-STAT3-tyrosine 705, anti-p38␣, antiphosphop38␣, anti-JAK1, antiphospho-JAK1, anti-JAK2, antiphospho-JAK2, and anti-cleaved Caspase 3 were from Cell Signaling Technology (Beverly, MA); anti-gp130 were from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA); anti-flag and anti-␤-actin were from Sigma (St. Louis, MO) at a concentration of 1:1000]. Membranes were then washed and exposed to peroxidase-conjugated secondary antibodies (Amersham Bioscience, Little Chalfont, Buckinghamshire, UK). Immunoblots were imaged using a medical film processor (SRX-101A; Konica Minolta Medical & Graphic Inc., New York, NY).
Adenovirus injection
Adenovirus expressing FXR-VP16 or VP16 alone was prepared and purified as previously described (22) . Eight days after tail vein injection with 1 ϫ 10 9 plaque-forming units of the FXR-VP16 adenovirus or the control per mouse, the mice were euthanized. Livers and blood were collected for analysis.
Primary hepatocyte preparation
Primary hepatocytes were isolated and cultured as described previously (22) . GW4064 (2 M) (TOCRIS Bioscience, Ellisville, MO) was applied to the hepatocytes, and 24 h later 10 ng/ml mouse recombinant IL-6 (PeproTech, Rocky Hill, NJ) was used to induce STAT3 phosphorylation.
Hydrodynamic injection
The pRc/CMV-stat3C-flag and pRc/CMV plasmid vectors, as described previously (45) , were transfected into 8-wk-old male FXR mice via hydrodynamic injection through the tail vein, as described previously (32) . The volume of the plasmid solutions was 0.1 ml/g body weight with a concentration of 10 g/ml. the mice were injected with CCl 4 1 d after the infusion of the plasmids. Mice were euthanized and livers were removed for analysis 24 h later.
BA and serum ALT analysis
Total BAs were measured using the BA L3K assay kit, according to the manufacturer's instructions (Diagnostic Chemicals Limited, Oxford, CT). Serum ALT was measured at the City of Hope Helford Research Hospital.
Statistical analysis
Data are expressed as means Ϯ SD. Two-tailed Student's t test was used to determine differences between data groups. P Ͻ 0.05 was considered statistically significant, unless otherwise stated.
